搜索临床试验以:每天 200 微克倍氯米松
总计942个结果
-
Novartis完全的
-
BIO-CAT Inc.Atlantia Food Clinical Trials; Cork University Hospital完全的
-
AstraZenecaParexel完全的
-
National Health Research Institutes, TaiwanChang Gung Memorial Hospital; Tri-Service General Hospital; National Taiwan University Hospital... 和其他合作者招聘中
-
Göteborg UniversityVastra Gotaland Region主动,不招人
-
Winthrop University Hospital撤销
-
Fundacion Clinic per a la Recerca Biomédica撤销
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute... 和其他合作者完全的
-
ReveraGen BioPharma, Inc.University of Pittsburgh; Cooperative International Neuromuscular Research Group完全的
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Institut CurieHoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre Laboratories主动,不招人
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
St Vincent's Hospital MelbourneMerck Sharp & Dohme LLC未知
-
ANRS, Emerging Infectious DiseasesFlamel Technologies未知
-
MacroGenics终止反洗钱美国, 英国, 德国, 以色列, 西班牙, 法国, 意大利, 荷兰
-
Ontario Clinical Oncology Group (OCOG)Ortho Biotech, Inc.终止
-
Maastricht University Medical CenterDiabetes Fonds招聘中
-
VA Office of Research and DevelopmentUniversity of Pittsburgh招聘中
-
Assistance Publique - Hôpitaux de Paris完全的
-
National Cancer Institute (NCI)主动,不招人复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 复发性原发性纵隔大 B 细胞淋巴瘤 | 难治性原发性纵隔大 B 细胞淋巴瘤美国
-
National Cancer Institute (NCI)终止岛状甲状腺癌 | 复发性甲状腺癌 | IV 期滤泡性甲状腺癌 | IV 期乳头状甲状腺癌 | 未分化甲状腺癌 | III 期滤泡性甲状腺癌 | III 期乳头状甲状腺癌美国
-
Université de SherbrookeNestle Health Science招聘中